Navia MA |
Rational design of new immunosuppressive drugs. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083489
|
Song Z et al. |
FK 506 prevents islet xenograft rejection: a study in the pig-to-rat model. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083437
|
Terakura M et al. |
Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083380
|
Kaibori M et al. |
Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083347
|
Rao AS et al. |
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083302
|
Rastellini C et al. |
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083278
|
Stratta RJ |
Optimal immunosuppression in pancreas transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083263
|
Kaufman DB et al. |
Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083261
|
Humar A et al. |
Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083256
|
Kandaswamy R et al. |
Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083254
|
Damotte D et al. |
Morphologic features of large bowel biopsies in combined small and large bowel transplantations could predict clinical rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083252
|
Schulz T et al. |
Mycophenolate mofetil/prednisolone/single-shot ATG with tacrolimus or cyclosporine in pancreas/kidney transplantation: first results of an ongoing prospective randomized trial. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083251
|
Murase N et al. |
Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083238
|
Fischer L et al. |
Hepatitis G virus infection in liver transplant recipients. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083208
|
Rayes N et al. |
Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir--how effective is it? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083200
|
Molmenti E et al. |
Noncompliance after pediatric liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083164
|
Mueller AR et al. |
Is the use of marginal liver grafts justified? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083160
|
Kato T et al. |
Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083158
|
Lohmann R et al. |
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083151
|
|
Tacrolimus in renal transplantation: a comparison of induction vs noninduction therapy (triple therapy): three-month results. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083131
|